POC Diagnostic Platform Combines Immunoassay and Molecular Testing

An innovative diagnostic platform offers superior sensitivity across all sample types, including blood, compared to existing rapid tests, while maintaining a low-cost, user-friendly design. This platform not only demonstrates true lab-quality sensitivity, even with the most challenging clinical samples, but also maintains low invalid rates and minimal system downtime.

Cubit Diagnostics (Carlsbad, CA, USA) is further advancing the development of its integrated immunoassay and molecular benchtop analyzer, specifically designed for use in doctor’s offices and pharmacies, eliminating the need for multiple platforms and complicated testing workflows. The Cubit platform leverages a proprietary purification method and affordable microfluidic technologies to provide actionable results exactly when and where they are needed. By integrating cutting-edge target extraction technology with a simple, cost-effective design, CubitDx is addressing long-standing challenges in diagnostics. The result is laboratory-grade performance without sacrificing affordability, supporting the increasing trend of digital health and enabling more accessible care. The platform can simultaneously test up to 8 targets per run, offering comprehensive syndromic testing while performing both immunoassays and molecular testing on a single platform.

Image: The analyzer enables providers to screen, diagnose and test their patients in a single visit (Photo courtesy of Cubit)

While initially focused on COVID-19, Flu A, and Flu B, the CubitDx platform is designed to tackle a wide range of critical health issues, including sepsis, sexually transmitted diseases (STDs), HIV, and HPV in the future. Evaluation results show that the CubitDx platform’s COVID-19 assay provides higher sensitivity than standard rapid tests and matches the sensitivity of large, high-throughput clinical laboratory systems. With the ability to deliver lab-quality results in just 15 minutes at the point of care, the platform aims to bring high-performance diagnostics closer to patients, improving both outcomes and accessibility worldwide. Offering affordable, high-sensitivity diagnostics for both resource-rich and cost-sensitive markets, the CubitDx platform has the potential to revolutionize healthcare access globally, from U.S. hospitals to underserved communities across Asia and Africa.

Related Links:
Cubit Diagnostics